Johnson & Johnson Cv Rx, Inc. Transaction History
Johnson & Johnson
- $293 Million
- Q4 2024
A detailed history of Johnson & Johnson transactions in Cv Rx, Inc. stock. As of the latest transaction made, Johnson & Johnson holds 4,103,430 shares of CVRX stock, worth $56.8 Million. This represents 17.73% of its overall portfolio holdings.
Number of Shares
4,103,430
Previous 4,103,430
-0.0%
Holding current value
$56.8 Million
Previous $36.2 Million
43.81%
% of portfolio
17.73%
Previous 11.52%
Shares
2 transactions
Others Institutions Holding CVRX
# of Institutions
95Shares Held
15.4MCall Options Held
76.5KPut Options Held
6.3K-
Nea Management Company, LLC Timonium, MD2.03MShares$28.1 Million1.83% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT921KShares$12.8 Million1.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA910KShares$12.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY876KShares$12.1 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY628KShares$8.7 Million0.0% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $285M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...